Literature DB >> 27904254

Liver Infarction after Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma in the Setting of a Large Portosystemic Shunt.

Benjamin V Park1, Ron C Gaba1, R Peter Lokken1.   

Abstract

Entities:  

Year:  2016        PMID： 27904254      PMCID： PMC5088095          DOI： 10.1055/s-0036-1592319

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


× No keyword cloud information.
  23 in total

1.  Ischemic complications of transcatheter arterial chemoembolization in liver malignancies.

Authors:  P G Tarazov; V N Polysalov; K V Prozorovskij; I V Grishchenkova; E V Rozengauz
Journal:  Acta Radiol       Date:  2000-03       Impact factor: 1.990

Review 2.  Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Authors:  J-L Raoul; B Sangro; A Forner; V Mazzaferro; F Piscaglia; L Bolondi; R Lencioni
Journal:  Cancer Treat Rev       Date:  2010-08-17       Impact factor: 12.111

3.  Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?

Authors:  Ron C Gaba; Catherine M Rim; Ahmad Parvinian
Journal:  J Vasc Interv Radiol       Date:  2013-07       Impact factor: 3.464

4.  Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts.

Authors:  John T Miura; William S Rilling; Sarah B White; Robert A Hieb; Sean M Tutton; Parag J Patel; T Clark Gamblin; Eric J Hohenwalter
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

5.  Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival.

Authors:  Antoine Bouvier; Violaine Ozenne; Christophe Aubé; Jérôme Boursier; Marie Pierre Vullierme; Francine Thouveny; Olivier Farges; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2011-04-12       Impact factor: 5.315

6.  Hepatic infarction following abdominal interventional procedures.

Authors:  Hiroyasu Fujiwara; Susumu Kanazawa; Takao Hiraki; Hidefumi Mimura; Kotaro Yasui; Shiro Akaki; Takahito Yagi; Yoshio Naomoto; Noriaki Tanaka; Yoshio Hiraki
Journal:  Acta Med Okayama       Date:  2004-04       Impact factor: 0.892

7.  Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt.

Authors:  Yuo-Chen Kuo; Maureen P Kohi; David M Naeger; Ricky T Tong; K Pallav Kolli; Andrew G Taylor; Jeanne M Laberge; Robert K Kerlan; Nicholas Fidelman
Journal:  Cardiovasc Intervent Radiol       Date:  2013-07-18       Impact factor: 2.740

8.  Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?

Authors:  Maureen P Kohi; Nicholas Fidelman; David M Naeger; Jeanne M LaBerge; Roy L Gordon; Robert K Kerlan
Journal:  J Vasc Interv Radiol       Date:  2012-11-22       Impact factor: 3.464

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740
View more
  1 in total

1.  Transarterial Delivery of a Biodegradable Single-Agent Theranostic Nanoprobe for Liver Tumor Imaging and Combinatorial Phototherapy.

Authors:  Olena R Taratula; Oleh Taratula; Xiangjun Han; Younes Jahangiri; Yuki Tomozawa; Masahiro Horikawa; Barry Uchida; Hassan A Albarqi; Canan Schumann; Shay Bracha; Tetiana Korzun; Khashayar Farsad
Journal:  J Vasc Interv Radiol       Date:  2019-06-13       Impact factor: 3.464
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.